1. Home
  2. AMWL vs RANI Comparison

AMWL vs RANI Comparison

Compare AMWL & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$9.91

Market Cap

91.2M

Sector

Technology

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.68

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
RANI
Founded
2006
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.2M
106.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
AMWL
RANI
Price
$9.91
$0.68
Analyst Decision
Hold
Strong Buy
Analyst Count
6
4
Target Price
$7.40
$7.50
AVG Volume (30 Days)
62.0K
634.8K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
57.06
57.14
EPS
N/A
N/A
Revenue
N/A
$1,633,000.00
Revenue This Year
N/A
$274.77
Revenue Next Year
$4.24
$79.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
58.85
52 Week Low
$3.71
$0.39
52 Week High
$9.96
$3.87

Technical Indicators

Market Signals
Indicator
AMWL
RANI
Relative Strength Index (RSI) 62.56 35.15
Support Level $8.06 $0.45
Resistance Level $9.96 $0.83
Average True Range (ATR) 0.54 0.05
MACD 0.01 -0.00
Stochastic Oscillator 76.09 20.70

Price Performance

Historical Comparison
AMWL
RANI

About AMWL American Well Corporation

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: